The American Nurse Journal of the ANA emphasized the critical role nurses play in ensuring safe medication practices, referencing ECRI’s insights into the top patient safety concern of 2024: transitioning new clinicians from education into practice. Read more: https://hubs.la/Q02Y_8lt0
关于我们
ECRI is an independent, nonprofit organization improving the safety, quality, and cost effectiveness of care across all healthcare settings. The combination of evidence-based research, medical device testing, and knowledge of patient safety makes ECRI uniquely respected by healthcare leaders and agencies worldwide. For more than 50 years, ECRI has had an unwavering dedication to transparency and strict conflict-of-interest policies. The organization has earned a reputation as the trusted voice of unbiased, research-based assurance for tens of thousands of members around the world using its solutions to minimize risk and improve patient care. As a leading provider of spend and clinical data analytics and solutions, we provide comprehensive and unique market and competitive intelligence on a wide array of healthcare technologies. Our market intelligence includes transactional pricing, independent lab-based tested devices and equipment, safety alerts and history, evidence-based health technology assessments, and disruptive technologies on the horizon. ECRI has the only medical device testing labs in North America and the Asia Pacific where bio-engineers conduct hands-on independent device testing for safety and human factors usability. ECRI is designated an Evidence-based Practice Center by the U.S. Agency for Healthcare Research and Quality. ECRI and the Institute for Safe Medication Practices PSO is listed as a federally certified Patient Safety Organization by the U.S. Department of Health and Human Services.
- 网站
-
https://www.ecri.org
ECRI的外部链接
- 所属行业
- 医院和医疗保健
- 规模
- 501-1,000 人
- 总部
- Plymouth Meeting，Pennsylvania
- 类型
- 非营利机构
- 创立
- 1968
- 领域
- patient care、patient safety、comparative effectiveness、risk management、healthcare、healthcare research、healthcare technology、healthcare quality、medical devices、medical equipment planning、aging services、healthcare supply chain、COVID-19、medical devices、evidence-based medicine、infection prevention and control和ambulatory care
地点
ECRI员工
动态
-
New Blog | Enhancing Healthcare Decision-Making: Leveraging Data-Driven Value Analysis for Better Outcomes In healthcare, the decisions made during the value analysis process can significantly impact patient outcomes and operational efficiency. To make these decisions count, it's essential to rely on accurate, relevant data that spans clinical evidence, safety, financial impact, and market factors. By systematically gathering and analyzing this information, healthcare professionals can ensure that their choices are both effective and aligned with broader strategic goals. A robust value analysis process begins with evidence-based appraisal. This approach ensures that decisions are grounded in objective information rather than subjective judgment. By reviewing published clinical literature, regulatory status, and market factors, healthcare teams can make decisions that are both safe and effective. Keep reading: https://hubs.la/Q02TTy-G0 #healthcare #valueanalysis #decisionsupport
-
-
ECRI转发了
Human factors engineers specialize in understanding how complex work systems create opportunities for human error and how human factors engineering can be a powerful tool in mitigating human error and subsequent MPL claims. Learn more in this IML Online article by Patrice Tremoulet at ECRI: https://bit.ly/3CDvesV
-
-
?? Congratulations to Penn Medicine Lancaster General Health for winning Honorable Mention in ECRI’s 2024 Safety Excellence Award. ?? ???? Penn Medicine Lancaster General Health set out to improve the Root Cause Analysis (RCA) process for safety events. ? They achieved measurable success including a drop in the response time to safety events, expedited completion times on investigations, and higher levels of emotional wellbeing reported by staff involved in the process. Most notably there was a reduction in safety events. ?? Learn more about the ECRI Safety Excellence Award: https://hubs.la/Q02YVvdQ0
-
-
For many patients with schizophrenia, standard antipsychotic medications are insufficient – but a newly-approved combination of drugs may provide relief. Xanomeline, a medication that mimics the neurotransmitter acetylcholine, was previously investigated to treat schizophrenia, but was discontinued due to peripheral (non-brain) side effects. Recent clinical trials have demonstrated that trospium chloride, an FDA-approved anticholinergic medication that does not cross the blood-brain barrier, can mitigate these peripheral side effects. In September, the FDA approved the combination of xanomeline and trospium chloride for the treatment of schizophrenia in adults. View the latest Emerging Health Care Innovation Brief to learn more about this investigational treatment: https://hubs.la/Q02Yz2H30 #schizophrenia #mentalhealth #mentalhealthcare #patientcare #healthcare #innovation #horizonscanning #ecri
Emerging Health Care Innovation Brief: Treating Parkinson’s Disease and Schizophrenia (October 10-23, 2024)
pcori.org
-
Health Management recently featured ECRI’s insights on the future of at-home cardiac rehabilitation (CR). At-home and hybrid CR programs have proven effective, with comparable benefits to traditional center-based programs. ECRI’s evidence analysis found that assistive technology, including remote monitors, activity trackers, digital logs, and telemedicine consultations, help keep patients engaged and improve CR effectiveness. But the future availability of these programs hangs in the balance, dependent on the continuation of reimbursement policies set to end in December. Read more: The Future of At-Home Cardiac Rehabilitation - https://hubs.la/Q02Y_6L80
The Future of At-Home Cardiac Rehabilitation
healthmanagement.org
-
The ECRI Horizon Scanning team is excited to feature MaryEileen Aldana in this month’s Stakeholder Spotlight. As both a patient and caregiver reviewer for the Patient-Centered Outcomes Research Institute (PCORI) Healthcare Horizon Scanning System, MaryEileen’s insights help our research analysts understand the potential impact of emerging treatments for cancer, cardiovascular, and infectious diseases. Her unique experience on both sides of care allows her to offer critical feedback that enhances patient safety and improves healthcare outcomes. “Working on the Horizon Scanning System allows me to provide my perspective as both a patient and a caregiver,” shared MaryEileen. “I’m proud to be part of a process that bridges the gap between those giving care and those receiving it.” Thank you, MaryEileen, for your dedication and the invaluable perspective you bring to the healthcare community! Are you a patient or caregiver interested in sharing your insights with @ECRI_org analysts? Fill out a brief form, and a member of our team will be in touch: https://hubs.ly/Q02YJGfZ0 #patients #caregivers #advocate #researchadvocate #healthcare #patientcare #horizonscanning
-
-
There is currently no cure for Parkinson’s Disease (PD), but an experimental treatment is showing promise. Treatment with levodopa (L-dopa), a dopamine precursor, can initially reduce PD symptoms, but eventually leads to intolerable adverse effects believed to be caused by dopamine receptor overexcitation and desensitization. Tavapadon is an experimental, orally-administered dopamine receptor partial agonist (activator) designed to provide a better-tolerated alternative to levodopa. In an ongoing placebo-controlled clinical trial, treatment significantly improved motor function and activities of patients living with PD. View the latest Emerging Health Care Innovation Brief to learn more about this emerging treatment: https://hubs.la/Q02Yz4qt0 #parkinsonsdisease #pd #neurology #neurodegenerativedisorders #patientcare #healthcare #innovation #horizonscanning #ecri
Emerging Health Care Innovation Brief: Treating Parkinson’s Disease and Schizophrenia (October 10-23, 2024)
pcori.org
-
?? Congratulations to Owensboro Health for winning ECRI's 2024 Healthcare Supply Chain Excellence Award.?Their commitment to data analytics and best practices in supply chain management support quality patient care. ?? https://lnkd.in/gQ9_8vCK
Owensboro Health is proud to be named a 2024 Healthcare Supply Chain Excellence Award winner by ECRI! This honor recognizes our commitment to using best practices that ensure high-quality, cost-effective care. “Being recognized by ECRI is a testament to the hard work and dedication of our supply chain team,” said John Walker, Executive Director of Materials Management at Owensboro Health. “Our goal is to ensure every dollar spent benefits the health and well-being of our patients.”
-
-
ECRI's infection prevention experts assisted in the development of this educational resource for healthcare personnel in Pennsylvania to address Candida auris, a fungus that can cause severe, multidrug-resistant infections. Check out the video series to learn who is most at risk of the fungus; tips for surveillance, reporting and tracking; and targeted guidance for various groups of staff, from frontline nurses, to lab technicians, to environmental services teams. https://hubs.la/Q02YR0sl0
-